These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12806710)

  • 1. Laboratory monitoring of HIV/AIDS in a resource-poor setting.
    Glencross DK; Mendelow BV; Stevens WS
    S Afr Med J; 2003 Apr; 93(4):262-3. PubMed ID: 12806710
    [No Abstract]   [Full Text] [Related]  

  • 2. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.
    Kent DM; McGrath D; Ioannidis JP; Bennish ML
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S13-24. PubMed ID: 12822128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV treatment by ARV in resource-poor francophone countries].
    Lepère P; Milleliri JM
    Med Sante Trop; 2015; 25(3):237-44. PubMed ID: 26446740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel.
    Hirsch MS; Brun-Vézinet F; Clotet B; Conway B; Kuritzkes DR; D'Aquila RT; Demeter LM; Hammer SM; Johnson VA; Loveday C; Mellors JW; Richman DD;
    Top HIV Med; 2003; 11(4):150-4. PubMed ID: 12876334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less.
    Bélec L; Bonn JP
    Future Microbiol; 2011 Nov; 6(11):1251-60. PubMed ID: 22082287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DART trial: 'The doctor's dilemma' revisited.
    Nunes EP; Grinsztejn B; Schechter M
    J Antimicrob Chemother; 2011 May; 66(5):964-7. PubMed ID: 21393146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dried blood spots in HIV monitoring: applications in resource-limited settings.
    Johannessen A
    Bioanalysis; 2010 Nov; 2(11):1893-908. PubMed ID: 21083497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
    Elliott JH; Lynen L; Calmy A; De Luca A; Shafer RW; Zolfo M; Clotet B; Huffam S; Boucher CA; Cooper DA; Schapiro JM
    AIDS; 2008 Oct; 22(16):2053-67. PubMed ID: 18753937
    [No Abstract]   [Full Text] [Related]  

  • 9. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention?
    Menon S
    J Public Health Policy; 2010 Dec; 31(4):385-400. PubMed ID: 21119646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research as a path to wide-scale implementation of antiretroviral therapy in Africa.
    Sanne I; van der Horst C
    J HIV Ther; 2004 Sep; 9(3):65-8. PubMed ID: 15534564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three million HIV/AIDS sufferers could receive anti-retroviral therapy by 2005: new hope for those in developing world.
    Lepr Rev; 2002 Sep; 73(3):295-6. PubMed ID: 12449898
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving the clinic-laboratory-interface in the context of HIV diagnosis, treatment, and monitoring.
    Tucker TJ; Manyike PT
    Curr Opin HIV AIDS; 2017 Mar; 12(2):105-111. PubMed ID: 28079593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
    Joni J
    Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
    [No Abstract]   [Full Text] [Related]  

  • 15. Access to essential medications for HIV/AIDS in South Africa.
    Andrews S
    S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV causes AIDS: prevention is possible and treatment can be effective.
    S Afr Med J; 2002 Mar; 92(3):208-9. PubMed ID: 12040943
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring antiretroviral therapy in resource-limited settings: balancing clinical care, technology, and human resources.
    Hosseinipour MC; Schechter M
    Curr HIV/AIDS Rep; 2010 Aug; 7(3):168-74. PubMed ID: 20499290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of children with Kaposi sarcoma in resource limited settings.
    Molyneux E; Davidson A; Orem J; Hesseling P; Balagadde-Kambugu J; Githanga J; Israels T
    Pediatr Blood Cancer; 2013 Apr; 60(4):538-42. PubMed ID: 23255282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries.
    Colebunders R; Moses KR; Laurence J; Shihab HM; Semitala F; Lutwama F; Bakeera-Kitaka S; Lynen L; Spacek L; Reynolds SJ; Quinn TC; Viner B; Mayanja-Kizza H
    Lancet Infect Dis; 2006 Jan; 6(1):53-9. PubMed ID: 16377535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy where resources are limited.
    Reynolds SJ; Bartlett JG; Quinn TC; Beyrer C; Bollinger RC
    N Engl J Med; 2003 May; 348(18):1806-9. PubMed ID: 12724489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.